Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy

Cancer immunotherapy has made tremendous clinical progress in advanced-stage malignancies. However, patients with various tumors exhibit a low response rate to immunotherapy because of a powerful immunosuppressive tumor microenvironment (TME) and insufficient immunogenicity of tumors. Photodynamic t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Bin, Wei, Minjie, Yang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690913/
https://www.ncbi.nlm.nih.gov/pubmed/34987658
http://dx.doi.org/10.7150/thno.67300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690913/
https://www.ncbi.nlm.nih.gov/pubmed/34987658
http://dx.doi.org/10.7150/thno.67300

Ejemplares similares